Cyclins against cancer: A novel family of tumor antigens?

Nela Klein-Gonźlez; Eisei Kondo; Michael S. Von Bergwelt-Baildon

doi:10.2217/imt.10.48

Cyclins against cancer: A novel family of tumor antigens?

Nela Klein-Gonźlez, Eisei Kondo, Michael S. Von Bergwelt-Baildon

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	595-597
Number of pages	3
Journal	Immunotherapy
Volume	2
Issue number	5
DOIs	https://doi.org/10.2217/imt.10.48
Publication status	Published - Sep 2010
Externally published	Yes

Keywords

cell cycle
cyclin
tumor antigen

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2217/imt.10.48

Cite this

@article{200795a5246f457a904e59dffcfbb67c,

title = "Cyclins against cancer: A novel family of tumor antigens?",

keywords = "cell cycle, cyclin, tumor antigen",

author = "Nela Klein-Gon{\'z}lez and Eisei Kondo and {Von Bergwelt-Baildon}, {Michael S.}",

year = "2010",

month = sep,

doi = "10.2217/imt.10.48",

language = "English",

volume = "2",

pages = "595--597",

journal = "Immunotherapy",

issn = "1750-743X",

publisher = "Future Medicine Ltd.",

number = "5",

}

TY - JOUR

T1 - Cyclins against cancer

T2 - A novel family of tumor antigens?

AU - Klein-Gonźlez, Nela

AU - Kondo, Eisei

AU - Von Bergwelt-Baildon, Michael S.

PY - 2010/9

Y1 - 2010/9

KW - cell cycle

KW - cyclin

KW - tumor antigen

UR - http://www.scopus.com/inward/record.url?scp=77957566146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957566146&partnerID=8YFLogxK

U2 - 10.2217/imt.10.48

DO - 10.2217/imt.10.48

M3 - Editorial

C2 - 20874640

AN - SCOPUS:77957566146

VL - 2

SP - 595

EP - 597

JO - Immunotherapy

JF - Immunotherapy

SN - 1750-743X

IS - 5

ER -

Cyclins against cancer: A novel family of tumor antigens?

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this